June 3, 2017 Clinical Research/Diagn. Life Science Tools M&A, Partnerships

Bristol-Myers Squibb and QIAGEN Sign Agreement for Use of NGS Technology to Develop Gene Expression Profiles for Immuno-Oncology Therapies

NEW YORK and HILDEN, Germany, (June 3, 2017) – Bristol-Myers Squibb Company (NYSE: BMY) and QIAGEN(NASDAQ: QGEN; Frankfurt Prime Standard: QIA) have signed an agreement to explore the use of next-generation sequencing (NGS) technology to develop gene expression profiles (GEPs) as  predictive or prognostic tools for  use with Bristol-Myers Squibb novel immuno-oncology (I-O) therapies in... Read more

June 3, 2017 Licensing, IP, and Legal Life Science Tools

QIAGEN expands biomarker content portfolio to support greater use of molecular diagnostics for immuno-oncology therapies

Option to add new biomarkers for microsatellite instability (MSI) and mismatch repair (MMR) to QIAGEN’ s NGS panels Hilden, Germany, and Germantown, Maryland, June 3, 2017 – QIAGEN (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced it has received a worldwide license from The Johns Hopkins University for biomarkers that have been shown to play... Read more

June 3, 2017 PR/Corporate Product Launch

Roche presents new data for TECENTRIQ® (atezolizumab) and updates from across its cancer immunotherapy development programme at ASCO 2017

Basel, 03 June 2017 Roche presents new data for TECENTRIQ® (atezolizumab) and updates from across its cancer immunotherapy development programme at ASCO 2017 Data evaluated TECENTRIQ in novel combinations across a broad range of tumours including lung, kidney and melanoma Promising Phase II combination data with TECENTRIQ plus Avastin (bevacizumab) in advanced kidney cancer First... Read more

June 2, 2017 Life Science Tools Product Launch

Zymo Research to Launch Three New Kits for Microbiome Research at ASM Microbe 2017

Improves accuracy, decreases steps in a microbiomic workflow NEWS PROVIDED BY Zymo Research Corp. 02 Jun, 2017, 11:05 ET SHARE THIS ARTICLE NEW ORLEANS, June 2, 2017 /PRNewswire/ — Zymo Research Corp. will introduce the newest in its line of kits for microbiomic research. The AccuBIOME™ Amplicon Sequencing Kit utilizes real-time PCR instead of regular PCR... Read more

June 2, 2017 Clinical Research/Diagn. Lab Top-10 M&A, Partnerships

Agilent Technologies and Agendia Sign Agreement on Molecular Cancer Diagnostics

Agreement Accelerates the Development of Tests to Help Assess Risk of Disease Recurrence in Women with Early-Stage Breast Cancer SANTA CLARA, Calif., June 2, 2017 Agilent Technologies Inc. (NYSE: A) and Agendia, Inc. today jointly announced an agreementto expand their relationship to include the development of an RNA-Seq kit version of Agendia’s currently marketed MammaPrint... Read more

June 2, 2017 Lab Top-10 PR/Corporate

Bruker Corporation to Present at Investor Conferences

BILLERICA, Mass., June 2, 2017 /PRNewswire/ — Bruker Corporation (NASDAQ: BRKR) announced today it will present at the following conferences: Jefferies 2017 Healthcare Conference, New York, NYThursday, June 8, 2017, at 1:30 p.m. Eastern TimeFrank Laukien, President and Chief Executive OfficerJuergen Srega, President, Bruker CALID Group William Blair 37th Annual Growth Stock Conference, Chicago, ILTuesday, June... Read more

June 2, 2017 PR/Corporate

Tecan appoints Erik Norström Head of Corporate Development

Männedorf, Switzerland, June 2, 2017 – The Tecan Group (SIX Swiss Exchange: TECN) announced today that Erik Norström has been appointed Head of Corporate Development and a member of the Management Board. He will assume his new position at Tecan no later than December 1, 2017.Erik Norström held a number of Corporate Development and M&A... Read more

June 2, 2017 M&A, Partnerships

Xylem affirms its strong support for the Paris Climate Agreement

RYE BROOK, N.Y.–(BUSINESS WIRE)–Jun. 1, 2017– Following today’s announcement that the United States will withdraw from the Paris Climate Agreement, Xylem, a leading global water technology company, issued the following statement: “Addressing the realities of climate change is an opportunity to create shared value among all stakeholders, and Xylem remains committed to doing our part... Read more

June 1, 2017 Molecular Spectroscopy Product Launch

Rigaku announces 6th Generation MiniFlex benchtop XRD system

The 6th generation Rigaku MiniFlex X-ray diffraction system is designed for enhanced performance and flexibility June 1, 2017 – Tokyo, Japan. X-ray scientific, analytical and industrial instrumentation manufacturer Rigaku Corporation has announced the new 6th generation Rigaku MiniFlex benchtop X-ray diffraction (XRD) instrument. The new MiniFlex X-ray diffractometer is a multipurpose analytical instrument that can... Read more